Orion Infusion Statistics

Total Valuation

Orion Infusion has a market cap or net worth of BDT 7.32 billion. The enterprise value is 7.61 billion.

Market Cap	7.32B
Enterprise Value	7.61B

Important Dates

The last earnings date was Tuesday, April 29, 2025.

Earnings Date	Apr 29, 2025
Ex-Dividend Date	Dec 5, 2024

Share Statistics

Orion Infusion has 20.36 million shares outstanding. The number of shares has decreased by -0.35% in one year.

Current Share Class	20.36M
Shares Outstanding	20.36M
Shares Change (YoY)	-0.35%
Shares Change (QoQ)	-0.27%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	n/a

Valuation Ratios

The trailing PE ratio is 177.18.

PE Ratio	177.18
Forward PE	n/a
PS Ratio	10.85
PB Ratio	22.88
P/TBV Ratio	22.88
P/FCF Ratio	4,280.72
P/OCF Ratio	2,968.02
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 72.26, with an EV/FCF ratio of 4,452.34.

EV / Earnings	184.72
EV / Sales	11.28
EV / EBITDA	72.26
EV / EBIT	90.74
EV / FCF	4,452.34

Financial Position

The company has a current ratio of 0.93, with a Debt / Equity ratio of 0.99.

Current Ratio	0.93
Quick Ratio	0.28
Debt / Equity	0.99
Debt / EBITDA	3.01
Debt / FCF	185.47
Interest Coverage	2.35

Financial Efficiency

Return on equity (ROE) is 13.22% and return on invested capital (ROIC) is 8.47%.

Return on Equity (ROE)	13.22%
Return on Assets (ROA)	6.34%
Return on Invested Capital (ROIC)	8.47%
Return on Capital Employed (ROCE)	24.08%
Revenue Per Employee	940,229
Profits Per Employee	57,415
Employee Count	718
Asset Turnover	0.82
Inventory Turnover	2.77

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -39.78% in the last 52 weeks. The beta is -2.32, so Orion Infusion's price volatility has been lower than the market average.

Beta (5Y)	-2.32
52-Week Price Change	-39.78%
50-Day Moving Average	388.51
200-Day Moving Average	373.97
Relative Strength Index (RSI)	35.60
Average Volume (20 Days)	119,041

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Orion Infusion had revenue of BDT 675.08 million and earned 41.22 million in profits. Earnings per share was 2.03.

Revenue	675.08M
Gross Profit	284.27M
Operating Income	83.92M
Pretax Income	48.40M
Net Income	41.22M
EBITDA	97.48M
EBIT	83.92M
Earnings Per Share (EPS)	2.03

Full Income Statement

Balance Sheet

The company has 23.69 million in cash and 317.21 million in debt, giving a net cash position of -293.52 million or -14.42 per share.

Cash & Cash Equivalents	23.69M
Total Debt	317.21M
Net Cash	-293.52M
Net Cash Per Share	-14.42
Equity (Book Value)	319.93M
Book Value Per Share	15.81
Working Capital	-35.80M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 2.47 million and capital expenditures -756,437, giving a free cash flow of 1.71 million.

Operating Cash Flow	2.47M
Capital Expenditures	-756,437
Free Cash Flow	1.71M
FCF Per Share	0.08

Full Cash Flow Statement

Margins

Gross margin is 42.11%, with operating and profit margins of 12.43% and 6.11%.

Gross Margin	42.11%
Operating Margin	12.43%
Pretax Margin	7.17%
Profit Margin	6.11%
EBITDA Margin	14.44%
EBIT Margin	12.43%
FCF Margin	0.25%

Dividends & Yields

This stock pays an annual dividend of 1.20, which amounts to a dividend yield of 0.33%.

Dividend Per Share	1.20
Dividend Yield	0.33%
Dividend Growth (YoY)	20.00%
Years of Dividend Growth	1
Payout Ratio	16.79%
Buyback Yield	0.35%
Shareholder Yield	0.67%
Earnings Yield	0.56%
FCF Yield	0.02%

Dividend Details

Stock Splits

The last stock split was on December 4, 2011. It was a forward split with a ratio of 10.

Last Split Date	Dec 4, 2011
Split Type	Forward
Split Ratio	10

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a